9,11-EPOXY-1,21-DIHYDROXY-4,16-DIMETHYL-19-NORPREGNA-1,3,5(10)-TRIEN-20-ONE, (9.BETA.,11.BETA.,16.ALPHA.)-
UNII V9M65AX39K
Substance Identification & Data
This profile provides standardized clinical and technical data for 9,11-epoxy-1,21-dihydroxy-4,16-dimethyl-19-norpregna-1,3,5(10)-trien-20-one, (9.beta.,11.beta.,16.alpha.)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) V9M65AX39K.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 916347-23-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C22H28O4 RDRZUWZDDTXZAA-WEWANGQWSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 9,11-epoxy-1,21-dihydroxy-4,16-dimethyl-19-norpregna-1,3,5(10)-trien-20-one, (9.beta.,11.beta.,16.alpha.)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.